# US 2016/0235060 A1 · Biofilm inhibitor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0235060 A1
- Document ID: US20160235060A1
- Status: Published application
- Kind: A1
- Application number: 15/057,840
- Filed: 2016-03-01
- Published: 2016-08-18
- Earliest claimed: 2012-03-13
- Assignees: Fuji Chemical Co., Ltd.
- Applicants: Fuji Chemical Co., Ltd.
- Inventors: Naoki Ohno; Akiko Kawano; Takayasu Inoue; Hiroshi Isobe
- Web page: https://patentgrep.com/patent/US20160235060A1

## CPC

- A01N 37/18: containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
- A01N 43/16: with oxygen as the ring hetero atom
- A61K 36/06: Fungi, e.g. yeasts
- A61K 36/899: Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K 38/168: {from plants}
- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A61P 31/04: Antibacterial agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07H 5/06: Aminosugars
- C07K 14/4726: {Lectins}
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The biofilm inhibitor of the present invention contains a lectin, at least one recognizable sugar chain of which is N-acetylglucosamine (GlcNAc).

## Claims

### Claim 1

A method for inhibiting a biofilm, the method comprising:
applying a lectin to a surface for inhibiting biofilm formation, the lectin being an extract from one or more natural products selected from the group consisting of bitter gourd, pokeweed, gorse, mushrooms, wheat and jack bean, the lectin being purified to a concentration that is effective against biofilm formation and the lectin recognizing at least one sugar chain of N-acetyl glucosamine, the lectin being a concentration of 0.0001 mg/mL to a saturation concentration.

### Claim 2 (depends on 1)

The method according to claim 1, wherein at least one recognizable sugar chain of the lectin is sialic acid (Sia).

### Claim 3 (depends on 2)

The method to claim 2, wherein the lectin is an extract from mushroom, wheat, or mushroom and wheat.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the lectin has a property of at least one of the following (1) and (2):
(1) property that peels off at least one of biofilms adhering to an adherent body and bacteria to form biofilms from the adherent body; and
(2) property to aggregate microorganisms that form biofilms.

### Claim 5 (depends on 1)

The method according to claim 1, wherein applying the lectin to the surface inhibits a biofilm formed by one or more of microorganisms selected from the group consisting of Staphylococcus aureus, Candida albicans, Pseudomonas aeruginosa, and E. coli.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the concentration of the lectin is from 0.0001 mg/mL to 2 mg/mL.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the concentration of the lectin is from 0.0001 mg/mL to 1 mg/mL.

### Claim 8

A method for removing a biofilm, the method comprising:
applying a lectin to a biofilm, the lectin being an extract from one or more natural products selected from the group consisting of bitter gourd, pokeweed and gorse, the lectin being purified to a concentration that is effective to cause peeling of the biofilm and the lectin recognizing at least one sugar chain of N-acetyl glucosamine, the lectin being a concentration of 0.0001 mg/mL to a saturation concentration.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the concentration of the lectin is from 0.0001 mg/mL to 2 mg/mL.

### Claim 10 (depends on 8)

The method according to claim 8, wherein the concentration of the lectin is from 0.0001 mg/mL to 1 mg/mL.

### Claim 11 (depends on 8)

The method according to claim 8, wherein the lectin has a property to aggregate microorganisms that form biofilms.

### Claim 12 (depends on 8)

The method according to claim 8, where in the application of the lectin causes peeling of a biofilm formed by one or more of microorganisms selected from the group consisting of Staphylococcus aureus, Candida albicans, Pseudomonas aeruginosa, and E. coli.
